An open-label multicenter phase II study of Imatinib mesylate (Glivec) treatment of patients with malignant peripheral nerve sheath tumors

Update Il y a 4 ans
Reference: EUCTR2005-004774-24

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess response in patients with MPNST treated with Imatinib. Response is defined as at least stable disease according to RECIST criteria.


Inclusion criteria

  • malignant nerve sheath tumor

Links